Balasa Dinverno & Foltz LLC Abb Vie Inc. Transaction History

Balasa Dinverno & Foltz LLC

$1.58 Billion
Q3 2022

A detailed history of Balasa Dinverno & Foltz LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 29,085 shares of ABBV stock, worth $5.24 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

29,085

Previous 31,946 8.96%

Holding current value

$5.24 Million

Previous $4.89 Million 20.21%

% of portfolio

0.25%

Previous 0.31%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$134.21 - $153.93 $383,974 - $440,393	-2,861 Reduced 8.96%	29,085 $3.9 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $198,860 - $252,817	1,445 Added 4.74%	31,946 $4.89 Million
Q1 2022 Apr 25, 2022	BUY	$131.98 - $163.75 $698,966 - $867,220	5,296 Added 21.01%	30,501 $4.95 Million
Q4 2021 Jan 26, 2022	SELL	$107.43 - $135.93 $411,564 - $520,747	-3,831 Reduced 13.19%	25,205 $3.41 Million
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $90,972 - $103,266	-855 Reduced 2.86%	29,036 $3.13 Million
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $41,978 - $46,766	399 Added 1.35%	29,891 $3.37 Million
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $550,578 - $606,120	5,382 Added 22.32%	29,492 $3.19 Million
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $376,049 - $507,706	4,672 Added 24.04%	24,110 $2.58 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $201,630 - $236,648	2,347 Added 13.73%	19,438 $1.7 Million
Q2 2020 Aug 07, 2020	SELL	$73.37 - $98.18 $1.68 Million - $2.25 Million	-22,923 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $111,843 - $169,567	1,734 Added 8.18%	22,923 $1.75 Million
Q4 2019 Jan 22, 2020	BUY	$72.13 - $90.25 $69,100 - $86,459	958 Added 4.74%	21,189 $1.88 Million
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $270,751 - $325,520	4,299 Added 26.98%	20,231 $1.53 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $72,927 - $93,217	-1,110 Reduced 6.51%	15,932 $1.16 Million
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $76,831 - $90,426	-996 Reduced 5.52%	17,042 $1.37 Million
Q4 2018 Feb 04, 2019	SELL	$77.85 - $96.01 $67,495 - $83,240	-867 Reduced 4.59%	18,038 $1.66 Million
Q3 2018 Oct 24, 2018	BUY	$88.91 - $98.84 $68,905 - $76,601	775 Added 4.27%	18,905 $1.79 Million
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $31,333 - $37,074	349 Added 1.96%	18,130 $1.68 Million
Q1 2018 Apr 23, 2018	BUY	$92.01 - $123.21 $47,017 - $62,960	511 Added 2.96%	17,781 $1.68 Million
Q4 2017 Feb 05, 2018	BUY	$89.56 - $98.21 $24,539 - $26,909	274 Added 1.61%	17,270 $1.67 Million
Q3 2017 Oct 18, 2017	BUY	$69.85 - $89.22 $1.19 Million - $1.52 Million	16,996	16,996 $1.51 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.

Account

Balasa Dinverno & Foltz LLC Abb Vie Inc. Transaction History